Evidence map›Paper›PMID 42050359›Full record

ReviewBiotechnology progress

Protein hydrolysates in cell culture: Toward multi-omics characterization.

Michelle Combe, Brandon M Wrage, Angel Varela-Rohena, Stanislav Sokolenko

Abstract readReview
In one paragraph

Review in Biotechnology progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michelle CombeProcess Engineering and Applied Science, Dalhousie University, Halifax, Nova Scotia, Canada.
Brandon M WrageKerry, BioPharma Research Development and Applications, Beloit, Wisconsin, USA.
Angel Varela-RohenaKerry, BioPharma Research Development and Applications, Beloit, Wisconsin, USA.
Stanislav SokolenkoProcess Engineering and Applied Science, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0002-3837-8282

Funding

Dalhousie UniversityGood Food Institute 21-CM-CA-EG-1-04Mitacs IT43001Natural Sciences and Engineering Research Council of Canada RGPIN-2019-04694
6 · The paper itself

Abstract

The high cost of conventional cell culture media has driven demand for sustainable, cost-effective serum-free formulations in biopharmaceutical manufacturing and cultivated meat production. Although plant- and yeast-derived hydrolysates are generally considered to be promising additives, significant variability in raw materials and processing conditions results in substantial compositional and batch-to-batch differences between products, making it challenging to predict effectiveness in cell culture a priori. This review examines hydrolysate media additives through the specific lens of comprehensive multi-omic characterization as a means of addressing this uncertainty. While typical characterization is often limited to metrics such as degree of hydrolysis or color, detailed metabolomic and peptidomic profiling remains uncommon. We identify a gap in systematic, high-resolution characterization and argue that integrating compositional and bioactivity analyses is essential to transition hydrolysates from undefined inputs toward semi-defined media components.

Indexed as

Cell Culture TechniquesProtein HydrolysatesAnimalsCulture MediaHumansMetabolomicsMultiomicsProteomicsCulture MediaProtein Hydrolysatescell culturehydrolysatemetabolomicspeptidomics

Identifiers

PMID42050359
PMCPMC13441372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.